31 DAFTAR PUSTAKA
1. Weatherall DJ, Clegg JB. The ß- thalassaemias Dalam: Weatherall DJ, Clegg JB, penyunting. The thalassaemia syndrome. Edisi ke 4. London: Blackwell science; 2001. h.287-356.
2. Galanello R, Origa R.Beta-thalasssemia. Orphanet J of Rare Disease. 2010; 5:11-5.
3. Olivieri NF, Brittenham GM. Iron-chelating therapy and the treatment of thalassemia. Blood J. 1997; 89:739-61.
4. Najafipour F, Aliashgarjadeh A, Niafar M, Mobaseri M, Agamohamadzadeh N, Sorkhabi RS. Evaluation of glucose metabolisme, thyroid function, growth and development pattern and calcium stastus in patients with thalassemia major. Medwel J. 2008;3:867-73.
5. Hamidah A, Rahmah R, Azmi T, Aziz J, Jamal R. Short stature and truncal shortening in transfusion dependent thalassemia patients: result from a thalassemia center in Malaysia. Shouteast Asian J. 2001;32:625-30.
6. Moayeri H, Oloomi Z. Prevalence of growth and puberty failure with respect to growth hormone and gonadotropin secretion in beta-thalassemia major. Arc Iranian. 2006;9:329-34.
7. Bhala AK, Marwaha RK, Kaur H. Longitudinal growth attainments of transfusion dependent ß-thalassemia children. Mankin quarterly. 2008;48:484-93.
8. Saxena A. Growth retardation in thalassemia major patients. Int J Hum Genet. 2003; 237-46.
9. Kyriakou A, Skordis N. Thalassemia and aberration of growth and puberty. Medit J Hemat Infec Dis. 2009;4:1-8.
32 11. Grimberg A, Leon DD. Disorders of growth. Dalam: Mosang T, penyunting.
Pediatric Endocrinology. Edisi I. Philadelphia: Elsevier Mosby; 2005. h.127-67. 12. Batubara J, Susanto R, Cahyono HA. Pertumbuhan dan gangguan pertumbuhan.
Dalam: Batubara J, Trijaya B, Pulungan AB, penyunting. Buku ajar endokrinologi anak. Edisi I. Jakarta: Ikatan Dokter Anak Indonesia; 2010. h.19-41.
13. Patel L, Clayton PE. Normal and disordered growth. Dalam: Brook CGD, Clyton PE, Brown RS, Savage MO, penyunting. Clinical Pediatric Endocrinology. Edisi ke-5. Massachusette: Blackwell; 2005. h.90-111.
14. Dubey AP, Parakh A, Dublish S. Current trends of the management of beta thalassemia. Ind J Pediatr. 2008;7:739-43.
15. Cappellini MD, Congenite CA, Cohlen A, Piga A, Porter J. Guideline for the clinical management of thalassemia. Edisi ke-2 revisi. Cyprus: Thalassemia International Federation; 2011. h.64-70.
16. Ibrahim HM, Ayob Y, Mahayiddin AA, Sathar J, Musa Z, Bakri R, dkk. Management of transfusion dependent thalassaemia. Malaysia:Ministry of Health Malaysia; 2009.h.1-84.
17. Skordis N. Endocrine investigation and follow up in thalassemia: times for specific guimLines. Thalassemia reports. 2011;1:1-16.
18. Sanctis V, Urso, Scialpi, Mangiagli . Endocrine complications in ß-thalassemia major. Dalam: Maggio A, Hoffbrand AV, penyunting. Clinical aspects and therapy of haemoglobinopathies. Italy: Proprieta letteraria riservata; 2004.h.293-310.
19. Faranoush M, Rahiminejad MS, karamizadeh Z, Ghorbani R, Owji SM. Zinc supplementation effect linear growth in transfusion dependent ß thalassemia. IJBC. 2008;1:29-32.
20. Prabhu R, Prabhu V, Prabhu RS. Kelebihan besi in beta thalassemia –a revew. J Biosci Tech. 2009;1;20-31.
33 22. Mehvar A, Azarkeivan A, Faranoush M, Mehvar N, Saberinedjhad J, Ghorbani R. Endocrinophaties with ransfution dependent betha thalassemia. Pediatr Hem Onc. 2008; 25:187-94.
23. Shamshirzas AA, Bekheirnia MR, Kamgar M, Pourzahedgilani N, Bouzari N, Habibzadeh M, dkk. Metabolic and endocrinologic complications in beta-thalassemia major: a multicenter study in Taheran. BMC Endocrine Disorders. 2003; 3:1-6.
24. Khan FUR, Khan MH, Ayub T, Shah SH. Frekuency of complications in beta thalassemia major in D.I. Khan. Biomedica. 2007; 23:31-3.
25. Soliman AT, Khalafallah H, Ashour R. Growth and factors affecting it in thalassemia major. Hemoglobin. 2009; 33:116-26.
26. Low LCK. Growth of children with ß-thalassemia major. Indian J Ped. 2005; 72:159-63.
27. Paulev PE, Calleja GZ. Other hormones and disorders. Dalam : Paulev PE, Calleja GZ, penyunting. New human fisiology. Edisi ke-2. Copenhagen Denmark. Elsevier; 2010.h.251-3.
28. Karamifar H, Amirhakimi GH. Linier growth deficiency in ß-thalassemia patiens: is it growth hormone dependent? IJMS. 2002; 27:47-50.
29. Fica S, Albu A, Vladareanu F, Barbu C, Bunghez R, Nitu L, dkk. Endocrine disorders in ß-thalassemia major: cross sectional data. Act Endocr. 2005; 1:201-12.
30. Roth C, Perkum A, Bartz M, Jarry H, Eber S, Lakomek M. Short stature and failure of pubertal development in thalassemia major; evidence for hypothalamic neurosecretory disfuncion of growth hormone secretion and defective pituitary gonadotropin secretion. Eur J pediatr. 1997; 156:777-83.
34 32. Reiter EO, D’Ercole AJ. Disorders of anterior pituitary gland, hypothalamus and growth. Dalam: Rudolf AM, Hotcler MK, Lister G, Siegel NJ, penyunting. Rudolf’s Pediatric. Edisi ke-23. California: McGraw-Hill; 2003: h.2002.
33. Rindang C, batubara JL, Amalia P, Satari H. Some aspects of thyroid dysfunction in thalassemia major patients with severe iron chelathing. Paediatr indones. 2011; 51:67-72.
34. Eshragi P, Tamaddoni A, Zarifi K, Mohammadhasani A, Aminzadeh M. Thyroid function in major thalassemia patients: is it related to height and chelation therapy? Casp J Inern Med. 2011; 2:189-93.
35. Angelucci E, Barosi G, Camaschella C, Cappelini DM, Cazzola , Galanello R. Italian society of hematology practice guidelines for the management of kelebihan besi in thalassemia major and related disorders. Haematologica. 2008; 93(5):741-52.
36. Sayani F, Warner M, Wu J, Rieger DW, Humphreys K, Odame I. GuimLines for the clinical care of patient with thalassemia in Canada. Thalassemia foundation of Canada.Toronto. 2009:15-38.
37. Nabavizadeh SH, Anushiravani A, Haghbin S. Evaluation of growth parameters in patients with thalassemia major. Hematology. 2007; 12(5):445-7.
38. Ware HM, Kwiatkowski JL. Evaluation and treatment of transfusional iron overload in children. Pediatr Clin N Am. 2013;1393-1406.
39. Au WY, Li CF, Fang JP, Chen GF, Sun X, Li CG, dkk. Assesment of iron overload in very young children with limited thalassemia care resources in South China. Hemoglobin. 2014; 38(2):119-26.
40. Theil EC. Ferritin: at the crossroads of iron and oxygen metabolism. Blood. 1999; 94:3205-311.
